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BACKGROUND: In our previous study, we found higher cytoglobin (Cygb) expression in keloid than normal tissue. Cytoglobin is a new globin family 
protein which function is still being studied to date. The 
purpose of this research is to elucidate the function of Cygb 
in human skin keloid fibroblasts (KFs), especially its role in 
intracellular reactive oxygen species (ROS) levels.
METHODS: The  study  was  conducted  on  human 
skin KFs obtained from primary culture. Inhibition 
of Cygb expression was achieved by using siRNA 
targeting  Cygb. We compared  the relative expression 
of  Cygb between treatment and control group, and its 
effect  on intracellular ROS levels. Gene expression was 
measured  using  quantitative  real-time polymerase  chain 
reaction (qRT-PCR)  while  the  ROS  level  counted  by 
dichlorodihydrofluorescein  diacetate  (DCFHDA)  assay. 
RESULTS: There was an increase in intracellular ROS 
levels in the small interfering RNA (siRNA) (+) Cygb 
group compared to control group (1.673 vs. 1.260; 1.773 
vs. 1.393; 1.710 vs. 1.360; respectively). There is a negative 
correlation between Cygb expression and ROS level 
(p<0.05; r=-0.651).
CONCLUSION: There is a negative correlation between 
Cygb expression and intracellular ROS levels, we suggest 
Cygb acts as a ROS scavenger in human skin KFs.
KEywORDS: skin keloid fibroblasts, cytoglobin, siRNA, 
ROS
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Abstract
Introduction
Keloid, also known as keloid disorder and keloidal scar, 
is a benign tumor that can grow beyond the wound limit 
and has a high recurrence rate.(1) In the skin, keloids are 
typically raised, firm, red to pink, and sometimes itchy.
(2) Keloid usually cause aesthetic problems so it can 
initiate psychological disorders in patients.(3) The exact 
cause of keloid to date is unknown. Presumably, there 
are abnormalities of wound healing process caused by an 
imbalance between the process of synthesis and collagen 
degradation.(2,4)
 It has been reported that skin keloid fibroblasts (KFs) 
have stronger proliferating activity.(3) In keloids, there is 
also a state of hypoxia and an increase in reactive oxygen 
species (ROS) production characterized by increased 
hypoxia-inducible factor (HIF)-1α expression and higher 
intracellular ROS levels than normal tissue.(5-7) One of the 
regulated genes regulated by HIF-1α is cytoglobin (Cygb).
(8-10)
 Currently, optimal treatment of keloid remains 
undefined (2), because there is still limited knowledge about 
factors that may play a role in keloid pathophysiology, 
include Cygb. Cygb is a new globin family protein which 
function is still widely studied to date. Cygb is found not 
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only in the cytoplasm but also in the nucleus so it is thought 
to have a wider function than other globin proteins.(11) 
Our findings in previous studies found that Cygb gene 
expression was higher in keloid compared to normal tissue.
(6) We suspect the high expression of Cygb is related to its 
ability to act as a ROS scavenger.(11) This study aims to 
elucidate the role of Cygb in human skin KFs.
Methods
Study Design
This research is an experimental in vitro research conducted 
on fibroblasts cell cultures taken from human skin keloid 
lesion. We collected keloid scar specimens from 3 patients 
treated at Budi Kemuliaan Hospital (Jakarta, Indonesia), 
who underwent a second subcutaneous operation and had 
keloids in their previous surgical wounds. All patients 
agreed to participate in this study  after receiving the inform 
consent. A clinical and pathological investigation from all 
keloid cases were fully proven. Each sample was divided 
into 2 groups, the group treated with small interfering RNA 
(siRNA) (+) Cygb and untreated group (as control). All 
experiment was repeated 3 times.
 The research was conducted in the laboratory of 
Biochemistry and Molecular Biology, Faculty of Medicine, 
Universitas Indonesia from August 2017 to May 2018. The 
study was reviewed and approved by Faculty of Medicine 
Universitas Indonesia Research Committee (No. 472/UN2.
F1/ETIK/2016).
Cell Culture and Treatment
The primary skin KFs culture has been establishing, as noted 
previously.(12) We were grown the specimens in Dulbecco 
Modified Eagle Medium (DMEM) and amplified it in 10% 
Fetal Bovine Serum (FBS) (Gibco, New York, USA), 1% 
Penicillin/Streptomycin and 1% Fungizone (Gibco). All 
specimens were  cultured  with  5%  CO2  at  37oC  in a 
humidified  incubator. For siRNA (+) Cygb group, skin KFs 
were treated with human siRNA (+) Cygb.
siRNA Transfection
The siRNA targeting Cygb (siRNA (+) Cygb) were 
purchased from Santacruz. During 24 hours, skin KFs cells 
grown to 50-60% confluence in antibiotic-free medium 
for in vitro transfection, and then transfected with siRNA 
(+) Cygb using siRNA Transfection Medium sc-36868 
(Santacruz) at dose 20 pmol according to the manufacturer’s 
protocol. Quantitative real-time polymerase chain reaction 
(qRT-PCR) analysis performed to validate the efficiency of 
silencing.
Dichlorodihydrofluorescein  Diacetate (DCFHDA) 
Intracellular levels of ROS were estimated by using the 
fluorescent dye 2',7'-Dichlorodihydrofluorescein diacetate 
(DCFHDA) (Invitrogen, California, USA). Cells which 
used as control and experimental were plated in a similar 
number. We were plated the skin KFs in 96-well plates 
at a density 1x104 cell/well, then for treatment group, we 
typically transfected it with siRNA (+) Cygb. Three days 
after transfection, the cells were incubated for 30 minutes 
with 10 μM of DCFHDA washed in phosphate-buffered 
saline (PBS). The absorbance of the cells in each group was 
monitored at an excitation of 490 nm and emission of 520 
nm using a microplate reader (Nanodrop Thermo Scientific 
Varioscan Flash) (Thermo Fisher Scientific, Massachusetts, 
USA).
qRT-PCR
Total RNA was extracted from skin KFs using TriPure 
Isolation Reagent (Promega, Wisconsin, USA) according 
to the manufacturer’s instructions. An amount of 50 
ng of total RNA isolate per 10 µL of RT reaction was 
performed using LightCycler® 480 RT-PCR with 
SensiFAST SYBR NoROX Kit  (Bioline, London, 
UK).  The specific primers for Cygb were Forward 
5’- CAGTTCAAGCACATGGAGGA -3’and Reverse 
5’-GTGGGAAGTCACTGGCAAAT–3’;  and  for  18S 
RNA were Forward 5’-AAACGGCTACCACATCCAAG-
3’and Reverse 5’- CCTCCAATGGATCCTCGTTA–3’. 
The 18S RNA  was  performed  as  an  internal  control. 
Then, the Livak  formula  was  deliberated  for  relative 
quantification  of  the target gene. All reactions were 
performed in duplicates.
Statistical Analysis
Data are presented as the mean±SD of triplicate experiments. 
The independent T-test was employed for statistical analysis, 
with significant differences determined as p<0.05.
Results
To analyze the effect of Cygb in human skin KFs, we 
generated transfection of siRNA targeting Cygb. The 
qRT-PCR analysis indicated that the expression of Cygb 
was obviously decreased by siRNA (+) Cygb (Figure 1) 
compared to control. Furthermore, we examined the effect 
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Figure 1. Comparison of relative expression of Cygb mRNA in 
KFs between siRNA (+) Cygb and control group. There was a 
decrease in Cygb mRNA expression in siRNA (+) Cygb compared 
to the control group. **p<0.05; *p<0.1; analized by independent 
T-test.
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Figure 2. Comparison of intracellular ROS level in KFs 
between siRNA (+) Cygb and control group. There was a 
increased in DCFHDA level in siRNA (+) Cygb compared to the 
control group. **p<0.05; *p<0.1; analized by independent T-test.
of Cygb inhibition on human skin KFs intracellular ROS 
level. As shown in Figure 2, treatment with siRNA (+) Cygb 
significantly increased the intracellular ROS level of human 
skin KFs.
 Figure 3 represents the correlation of Cygb mRNA and 
intracellular ROS levels in human skin KFs. The correlation 
between the Cygb mRNA and intracellular ROS levels is 
moderate negative correlation (Pearson, r=-0.651; p<0.05; 
n=27). This indicates that if the Cygb expression decreases 
then the ROS level will increase, or vice versa.
Discussion
There is a negative correlation between Cygb expression 
and intracellular ROS levels on human skin KFs. This 
observation is consistent with previous reports who showed 
that Cygb has a role as a ROS/reactive nitrogen species 
(RNS) scavenger. Similar to neuroglobin and cytochrome 
C, Cygb has a hexacoordinated structure and ability to 
detoxify radicals by reaction with their heme.(13) 
 Based on previous in vitro studies, the ability of 
Cygb has been proved. The Cygb had a peroxidase activity 
and able to create a bond with various ligands (such as 
oxygen, nitric oxide and other free radicals). It indicates the 
important  role of Cygb for scavenging the free radicals (i.e., 
reactive oxygen and nitrogen species) and modulating the 
cellular redox signaling than modulating the O2 metabolism.
(14,15)
 In this study, we used siRNA to suppress Cygb 
because siRNA is one of the recent methods mediating RNA 
interference effect with high sensitivity and specificity.(16) 
Singh, et al., showed that administration of Cygb siRNA 
in myoblast cells under normoxia increased intracellular 
ROS levels in a small number but statistically significant 
compared to controls. The difference is increased when 
cells are cultured under hypoxia.(14) Previous study 
reported knockout of Cygb in vitro and in vivo will induce 
cells to express proinflammatory genes and increase 
ROS production.(17) Another investigation in NRK49F 
cells show that Cygb has an antioxidative stress effect.
(11) McRonald, et al., also received similar results where 
Cygb overexpression can lower ROS levels and provide 
protection against prooxidant-induced injuries (such as 
lipid peroxidation and breakdown of DNA chains due to 
oxidative reactions). However, the study says that there 
is no evidence of elevated ROS levels after suppression 
by RNA interference (RNAi) on cells expressing Cygb at 
physiological levels.(18) This may be explained because 
besides Cygb cells have complex antioxidant systems 
to detoxify ROS. Under normal conditions, antioxidant 
enzymes will work together to remove the various ROS 
produced by free radical reactions (Cu/Zn-superoxide 
dismutase (SOD), Mn-SOD, catalase, and selenium-
glutathione peroxidase (GSH-Px)).(19)
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Figure 3. Correlation of Cygb mRNA and 
intracellular ROS level showed moderate 
negative correlation (Pearson, r=-0.651, 
p<0.05).
Conclusion
There is a negative correlation between Cygb expression 
and intracellular ROS levels, we suggest Cygb acts as a 
ROS scavenger in human skin KFs.
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